Do we have AHCA fatigue yet? It could end today if the House votes no but a yes vote likely means another couple months of debate as it moves to.
We finally had a 1%+ down day in the market, so we can finally stop seeing on the tweets about how long it has been since a 1% sell off..
A quick note on ESPR as I somehow missed the FDA news this morning that a couple of you kindly pointed out. This makes the move much more reasonable than.
Well, this is not going to be a good day for the sector and that wall at 300 in the IBB is likely safe for now. The key culprit is.
Certainly getting some more news and events that could be driving the sector but nothing really thesis changing, we need to wait for the end of the week with the.
I was not too busy to write yesterday but there was really nothing that I could find that was interesting enough to write about. I looked for something and there.
I think the sector has been rational the past couple of days in that good news is generally moving stocks higher and bad news lower. If there was a broader.
I have snuck into work during this Mardi Gras break but not much to write on so this will be a quick update and will likely be back later in.
Weakness (sort of) continuing in the sector but perhaps that is simply drifting or consolidation after its recent performance. In either case, it still seems like people are unwilling to.
A little bit of news since yesterday and I will focus on them but more broadly the sector seemed to struggle yesterday. It had been outperforming so a day of.
Some news to talk about today in a couple stocks and one idea I want to float that has been ruminating in my mind. The sector continues to do well.
We have some additional news yesterday but nothing that is necessarily positive for the sector. It certainly rallied in the afternoon and I suspect there is enough juice left for.
Some decent news this morning for the sector but not quite a robust reaction. Perhaps the sector needs to pause after its recent run or perhaps it will rally later.
A relatively slow start to the week, so I will start off with perhaps the most (maybe only) meaningful fundamental news and then highlight another stock that is very likely.
So I think we need to be prepared for some more backlash and bad press given the decision by Marathon to think it is business as usual. So far the.
The sector (and I guess you could argue the market in general) has been pretty dull the past couple of days. During the past year these periods of no news.
We had some earnings but the real potential mover of the sector is the meeting this morning with Trump. The headlines are still early but it looks like a net.
We obviously got some news and price action but most of it is explainable and somewhat predictable. I will highlight some of the news and focus on the BMY report.
Still a slow start to the week especially for an earnings week. I will highlight a couple biotech points and one non-biotech. In terms of the non-biotech, I am becoming.